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Abstract
Background Adenosine is an endogenous neuromodula-
tor in both the peripheral and central nervous systems.
Adenosine inhibits pain signals by hyperpolarizing neuro-
nal membrane.
Methods To clarify the effects of adenosine on pain sig-
nals, we tested intrathecal adenosine injection in two
neuropathic pains (spinal cord compression and chronic
constriction of sciatic nerve) and postoperative pain
(plantar incision).
Results In all three kinds of pain models, significant
shortening of withdrawal latencies to thermal stimulation
were detected from 24 h to 1 week after the surgery. Sig-
nificant improvements of pain sensation were observed in
all three models after intrathecal injection of Cl-adenosine
24 h after surgery. At 72 h after surgery, intrathecal
Cl-adenosine injection inhibited hyperalgesia in the two
neuropathic pain models but not in the postoperative pain
model. Adenosine A1R messenger RNA (mRNA) expres-
sion significantly decreased in the plantar incision model.
Adenosine A1R protein levels also decreased compared
with the other two models and normal control.
Conclusions These results suggest that adenosine effec-
tively inhibits pain signals in neuropathic pain but is less
effective in postoperative pain because of the decrease in
adenosine A1 receptors.
Introduction
A large number of patients suffer from sciatica, low back,
and postoperative pain, treating which is one of the most
important topics for clinicians in orthopedic surgery or
anesthesiology. However, knowledge about pain signals
remains insufficient. Nonsteroidal anti-inflammatory drugs
(NSAIDs) have been commonly used but are effective only
for treating inflammatory pain by inhibiting prostaglandin
production. Understanding endogenous pain modulatory
systems that alter nociceptive transmission in the nervous
system may lead to the development of pain treatment. The
opioid receptor (OR) and monoamine systems are the main
inhibitory transmission mechanisms against pain sensation.
Endogenous opioid receptor agonists are very powerful
analgesic mechanisms. At the spinal cord level, delta opi-
oid receptors play an important role in antinociception [1].
Clinically, lOR agonists, such as morphine, are commonly
used for treating rather serious pain, such as postoperative
pain. Monoamines, such as noradrenalin [2] and serotonin
[3], are also strong endogenous pain-relieving agents.
Monoamines inhibit pain signals by the activating c-ami-
nobutyric acid (GABA) signals [4]. Increasing monoam-
ines with reuptake inhibitors has been used for pain relief
in patients with several neuropathic pains [5]. We previ-
ously reported that serotonin reuptake inhibitors amelio-
rated neuropathic pain induced by spinal cord injury [6]. In
the study reported here, we focused on adenosine receptors,
another endogenous nerve transmission system. Adenosine
is an endogenous neuromodulator that inhibits synaptic
transmission in both the peripheral and central nervous
systems [7]. Adenosine A1 receptor activation can produce
postsynaptic inhibition by activating potassium (K?)
channels [8]. The working mechanism of adenosine A1
receptors on pain signals is believed to inhibit pain signals
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by hyperpolarization of the neuronal membrane. Mice
lacking adenosine A1 receptors exhibited increased noci-
ceptive responses [9, 10]. These reports indicate that
adenosine A1 receptor signal activation may become a new
therapeutic method for treating several kinds of pain. We
previously reported that selective adenosine A1 receptor
agonists [R-PIA: R(-)N6-(2phenylisopropyl) adenosine]
inhibited thermal hyperalgesia after spinal cord injuries in
rats [11]. To establish a clinical use for adenosine, we
examined which kinds of pain are the ideal targets for
adenosine treatment and the best timing for adenosine
application.
In the study reported here, to clarify the effects of
adenosine on pain signals, we tested intrathecal adenosine
injections in several kinds of animal pain models. In
addition, change of adenosine receptors in the spinal cord
was assessed by real-time polymerase chain reaction (PCR)
and immunohistochemistry.
Materials and methods
Animals
One hundred and one female Wistar rats (250 g, purchased
from Japan Clea Co., Japan) were used for this study.
Experiments were performed according to the ethical rec-
ommendations of the Committee for Research and Ethical
Issues of the International Association for the Study of Pain
[12]. The research protocol was accepted by the Ethical
Committee for Animal Experiments of Ehime University
(Ehime, Japan).
Plantar incision model (PI model)
A plantar incision (PI) was made similar to that described
by Brennan et al. [13]. A 1-cm longitudinal incision
through skin, fascia, and muscle was made in the left hind
paw. The skin was closed with two 4-0 nylon sutures.
Spinal cord mild-compression injury
model (SCI model)
The spinal cord compression model was produced
according to our previous reports [6, 11]. Under general
anesthesia with halothane, the rat spinal cord was carefully
exposed by removing the vertebral lamina at the 11th
vertebra. Direct compression was performed using a 20-g
weight, of which the point of contact to the dura consisted
of very soft and rounded silicone. The weight was gently
placed on the thoracic spinal cord extradurally for 20 min
(SCI). We observed no serious damage, such as
hyperextension, paresis of the hind limbs, or histological
hemorrhage with tissue destruction at the point of com-
pression. In some experiments, a laminectomy of the 11th
vertebra was performed without SCI (sham).
Chronic constriction injury of sciatic
nerve model (CCI model)
Our CCI model was produced according to our previous
report [14]. Under general anesthesia with halothane, the
sciatic nerve was carefully exposed at the middle of the
femur. Chronic constriction was produced by ligation in
the left side only. A 27-gauge needle was placed along
the sciatic nerve and the nerve and needle were ligated
using polyglycolic acid strings (4-0, Nesco Company,
Osaka, Japan) at four points. The intervals between con-
striction points were 1 mm. Too much constriction pro-
duces irreversible nerve damage; therefore, careful
constriction is required to produce the appropriate level of
damage. After the strings were inserted, the needle was
removed. The strings expand as they absorb moisture
after being placed in the animals. Therefore, constriction
slowly increases after the operation. Usually, stable
hypersensitivity, such as allodynia and hyperalgesia, was
observed 3 days after operation. Animals that did not
successfully reveal allodynia and hyperalgesia were
excluded from the study.
Intrathecal application of Cl-adenosine
Cl-adenosine (10 nmol in 10 ll; Research Biochemicals
Inc. MA,USA), a nonselective adenosine receptor agonist,
was intrathecally injected through the intervertebral fora-
men between L3 and L4 at 24 and 72 h after surgery. In
each model, animals injected with 10 ll of saline instead of
Cl-adenosine solution were defined as vehicles.
Evaluation of thermal hyperalgesia
To evaluate the withdrawal threshold of thermal paw
stimulation, we used the Hargreaves’ plantar test apparatus
(Ugo Basile, Varese, Italy). Rats were placed on a 2-mm-
thick glass floor. A mobile infrared heat generator with an
aperture of 10 mm diameter was aimed at the rat’s hind
paw from under the floor. When the rats felt pain and
withdrew their paw, the power was shut off and the reac-
tion time (paw withdrawal latency) was recorded auto-
matically. Shortening withdrawal latency indicated thermal
hyperalgesia. The experiments were repeated three times,
at 5-min intervals, on each paw. Averages of measurements
taken were used as data. The temperature of the glass floor
was kept at 22.5–23.5 C.
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Real-time PCR analysis for adenosine
A1R mRNA expression
In the CCI and the PI models, L4 and L5 lumbar spinal
segments were taken for messenger RNA (mRNA) mea-
surement. In the SCI model, 1 cm of the cord at the center
of the compressed part was taken. Spinal cord tissue was
dissected under RNase-free conditions, and samples were
stored at -80 C before use. Total RNA was extracted by
tissue homogenization in Trizol reagent, quantified by
absorbance at 260 nm, normalized, and reverse-transcribed
into first-strand complementary DNA (cDNA) using an
RNeasy mini kit (QIAGEN, MD, USA). For the A1R gene
(TaKaRa. Shiga, JAPAN), the forward primer was 50-AT
CGATACCTCCGAGTCAAGATCC-30 and the reverse
primer was 50-TCCAGTCTTGCTCTACCACACTCAG-30.
For the GAPDH gene (TaKaRa), the forward primer was
50-GGCACAGTCAAGGCTGAGAATG-30 and the reverse
primer was 50-ATGGTGGTGAAGACGCCAGTA-30.
Two-step real-time PCR denaturing, annealing, and
extension reactions were performed for 40 cycles of 15 s at
95 C and then 1 min at 60 C (for A1R and GAPDH).
Increasing curves of reporter dye fluorescence emission
were recorded and analyzed with the SYBR Premix Ex
TaqTM (TaKaRa) to determine the threshold cycle (Ct)
value. Each sample was run and analyzed in triplicate, and
Ct values for A1R were subtracted from Ct values of
GAPDH to yield DCt values. The average DCt was cal-
culated for the control group, and this value was subtracted
from the DCt of all other samples (including the control
group). This resulted in a DDCt value for all samples,
which was then used to calculate the fold induction of the
mRNA levels of A1R using the formula 2-DDCt, as rec-
ommended by the manufacture (Bio-Rad, Hercules, CA,
USA) [15, 16].
Immunohistochemistry
Animals were sacrificed by deep anesthesia followed by
decapitation. The spinal cord at the 11th vertebral level
(SCI model) and L4–L5 lumbar segments (lumbar
enlargement; CCI and PI models) were immediately
removed, and axial freezing microtome sections of 10-lm
thickness were prepared. The sections were fixed on glass
slides with 4 % paraformaldehyde in phosphate-buffered
saline (PBS) for 5 min. Then, after washing twice with
PBS, slices on the slides were exposed to an anti-adenosine
A1R antibody (Abcam, Inc. Cambridge, UK: 1 lg/ml in
PBS) overnight at 4 C. Slices were then washed twice
with PBS and exposed to a fluorescein isothiocyanate
(FITC)-conjugated anti-rabbit immunoglobulin G (IgG)
antibody (SIGMA, MO, USA: 20 lg/ml in PBS) for
30 min. Sections were then observed under fluorescent
microscopy.
Data analysis
For statistical analysis, analysis of variance (ANOVA),
followed by Fisher’s protected least significant difference
(PLSD), was used.
Results
In all three kinds of pain models, significant shortening of
withdrawal latencies were detected from 24 h to 1 week
after the surgery (Fig. 1). Hyperalgesia was seen only
ipsilaterally to the surgery side in the PI and CCI models.
In the foot contralateral to the operation, withdrawal
latencies against thermal stimulation was identical to that
in normal animals (11.1 ± 0.24 s).
In the postsurgical model (PI model; Fig. 2), apparent
thermal hyperalgesia was seen in the foot ipsilateral to the
PI in the vehicle animal both at 24 and 72 h after the
operation. When Cl-adenosine (10 nmol in 10 ll) was
applied 24 h after surgery, pain threshold returned to nor-
mal (P \ 0.05, 11.37 ± 0.97 s). However, the antihyper-
algesic action of Cl-adenosine was not seen when the
injection was done 72 h after the operation. In the CCI
model (Fig. 3), hyperalgesia was also seen in the foot
ipsilateral to sciatic nerve constriction in the vehicle animal
both at 24 and 72 h after the operation. Intrathecal injection
of Cl-adenosine normalized withdrawal threshold against
thermal stimulation at 24 (11.36 ± 0.69 s) and 72 h
(12.07 ± 0.19 s) after the operation. The difference of the
Fig. 1 Time course of withdrawal latency by thermal stimulation
following three kinds of pain models. After measurement of
withdrawal latencies, rats received operations. Plantar incision (PI;
n = 6), chronic constriction injury (CCI; n = 6), and spinal cord
injury (SCI; n = 15) were performed. Measurements were taken
every 24 h until the 7th day following operations. Data are the
mean ± standard error of mean (SEM). Statistical significance
compared with preoperation levels for each time point is represented
with an asterisk (*P \ 0.05)
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Cl-adenosine effect in the PI and CCI models was seen at
72 h after the operation. In the SCI model (Fig. 4), thermal
threshold decreased both at 24 and 72 h after the operation
compared with that in the sham-operated animals. Intra-
thecal injection of Cl-adenosine significantly (P \ 0.05)
increased withdrawal latency both at 24 (11.12 ± 0.55 s)
and 72 h (10.47 ± 0.67 s) after the operation.
Real-time PCR analysis was represented as folds to
normal mRNA content (Fig. 5). Twenty-four hours after
operation, adenosine A1R mRNA expression significantly
(P \ 0.05) decreased in the PI model (0.2 folds compared
with the normal level). In the SCI model, adenosine A1R
mRNA level decreased to 0.7 folds. On the other hand, in
the CCI model it remarkably increased (2.5 folds), at 72 h
after operation in all three models it moved toward the
normal level. However, in the PI model, it was still lower
than normal (0.7 folds).
Adenosine A1R protein expression was evaluated
immunohistochemically. In the normal animals, the A1
receptor was expressed mainly in lamina II of the dorsal
horn. Twenty-four hours after operation, A1 receptors were
maintained in all three models (data not shown). Three
days after operation, A1 receptors were rather increased in
the dorsal horn of the CCI model. A1 receptor levels in the
SCI model were similar to that in the normal animal. On
the other hand, A1 receptor proteins remarkably decreased
in PI models 3 days after operation compared to the other
two models and normal control (Fig. 6).
Discussion
The dorsal horn of the spinal cord is believed to be one of
the most important areas for pain signal transmission. In
the spinal cord, adenosine A1 receptors are mainly dis-
tributed in postsynaptic neuronal-cells bodies and
Fig. 2 Effects of Cl-adenosine on thermal stimulation in the plantar
incision model at 24 h (a) and 72 h (b) after surgery. Data are
mean ± standard error of mean (SEM) (n = 6 in each time point).
Asterisk statistical significance (*P \ 0.05)
Fig. 3 Effects of Cl-adenosine on thermal stimulation in the chronic
constriction injury model at 24 h (a) and 72 h (b) after surgery. Data
are mean ± standard error of mean (SEM) (n = 6 in each time point).
Asterisk statistical significance (*P \ 0.05)
Fig. 4 Effects of Cl-adenosine on thermal stimulation in the spinal
cord injury model at 24 h (a) and 72 h (b) after surgery. Data are
mean ± standard error of mean (SEM) (n = 6 in each time points).
Asterisk, statistical significance compared vehicle animal (*P \ 0.05)
Fig. 5 Comparison of adenosine A1R messenger RNA (mRNA)
expression by real-time polymerase chain reaction (PCR) analysis in
the normal group and the three pain models. Data are mean ± stan-
dard error of mean (SEM) (n = 3 in each column). Asterisk statistical
significance compared with normal group (*P \ 0.05)
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processes in dorsal superficial layers (lamina II) [17]. We
also found that dense adenosine A1 receptor proteins
existed in lamina II of the dorsal horn (Fig. 6). This area is
not only for adenosine signal transmission but is also the
main area of adenosine production. Ecto-50-nucleotidase is
a membrane-anchored protein that hydrolyzes extracellular
adenosine 50-monophosphate (AMP) to adenosine. Ecto-50-
nucleotidase is located on nociceptive neurons in dorsal
root ganglia and on axon terminals in lamina II (substantia
gelatinosa) of the spinal cord [18]. Thus, this area should
be a main spot of endogenous pain relief by adenosine
signaling.
We found the adenosine A1 receptor mRNA remarkably
decreased in the spinal cord after PI but increased after
sciatic nerve constriction (Fig. 5). This suggests that dif-
ferential working mechanisms of adenosine in pain mod-
ulation existed in postoperative and neuropathic pain
conditions. It is not clear why adenosine A1 receptor
expression in the spinal cord dorsal horn was enhanced in
our CCI models. A remarkable difference between the CCI
and PI models is microglia activation in the spinal cord.
Microglia proliferation and activation occurs in the spinal
cord in the CCI model [19]. On the other hand, microglial
activation was not evident following PI [20]. The activated
microglia in the spinal cord may enhance the pain signal by
releasing nitric oxide or cytokines. Meanwhile, adenosine
A1 receptor activation counteracts microglia proliferation
and activation after CNS injury [21]. Therefore, it is
possible that adenosine A1 receptor mRNA expression
enhanced to counteract the effect of activated microglia in
our CCI model.
The change in adenosine A1 receptor mRNA expression
of the SCI model was not remarkable compared with that in
the CCI model (Fig. 5). Adenosine receptor was compar-
atively maintained in the mild SCI model. Although acti-
vated microglia also enhanced adenosine A1 receptor
production in SCI model [22], direct ischemic damage
might scale back the amount of A1 receptors. The patho-
logical pain mechanism of the SCI model is different from
that in the CCI model. SCI-induced pain is reported to
induce inhibition of tonic descending inhibitory mecha-
nisms, such as serotonergic and noradrenergic signaling, in
the spinal cord [6]. Therefore, the working mechanisms of
injected Cl-adenosine were different between CCI and SCI
models. In the SCI model, injected Cl-adenosine may
compensate damaged descending inhibitory signaling from
brain to spinal cord. In the CCI model, in contrast, sensi-
tivity to adenosine was increased in the dorsal horn by
augmented adenosine A1 receptor expression.
The reason for decreased adenosine A1 receptor
expression in our PI model also remains unclear. Hippo-
campal A1 receptor immunoreactivity in rats with cortex-
kindled seizures remarkably decreased compared with that
in normal rats [23]. The number of A1 receptors in the
hippocampus was also decreased in aged rats compared
with young adult rats [24]. In aged rats, adenosine
Fig. 6 Adenosine A1R protein
expression in spinal cord dorsal
horn. Seventy-two hours after
operation, spinal cord sections
from the 11th vertebra of the
spinal cord mild-compression
(SCI) model and L4–L5 lumbar
segment [lumbar enlargement;
plantar incision (PI) and chronic
constriction injury of sciatic
nerve model (CCI) models and
normal rat] were stained by anti-
adenosine A1R antibody.
Normal rat (a), PI model (b),
CCI model (c), SCI model (d).
Apparent decrease in adenosine
A1R expression was observed in
PI model
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production is activated by the increase of ecto-50-nucleo-
tidase. In addition, the amounts of adenosine in the syn-
aptic cleft further increased due to the decrease in
adenosine transporter activity [24]. It is possible that
repetitive overstimulation of increased extracellular aden-
osine may induce adenosine A1 receptor expression inhi-
bition in these models. In the PI pain model, stimulation
from the hind paw may accelerate adenosine triphosphate
(ATP) release from the afferent nerve terminals in the
dorsal horn. The released ATP may be rapidly changed to
adenosine by abundantly existing ecto-50-nucleotidase.
Then, adenosine A1 receptor mRNA expression may be
depressed by overstimulation of adenosine in the same
manner as in aged or kindled rat. Released ATP, which is
the source of extracellular adenosine, may be depleted with
time; however, adenosine A1 receptor expression inhibi-
tion continued for several days after PI.
As adenosine is a common substance existing in the
entire nervous system, it inhibits nerve transduction at the
baseline level. When the adenosine A1 receptor was
blocked at the spinal cord level, the threshold of thermal
pain decreased (heat hyperalgesia) [11]. Therefore, when
adenosine A1 signal is reduced by decreasing adenosine A1
receptors, pain signals should be enhanced. If this phe-
nomenon is a rational control of the self-protection system,
A1 receptor inhibition may induce hyperalgesia as cau-
tionary notices to avoid further nociception. The striking
decrease of A1 receptor mRNA occurred 24 h after PI
(Fig. 5), mRNA level recovered within another 2 days, and
change in A1 receptor protein occurred later than that in
mRNA level. Decreased A1 receptor protein was apparent
3 days after PI (Fig. 6). This indicates that desensitizing
signals from adenosine are not effective for several days
after incision. On the other hand, the desensitizing mech-
anism of adenosine signals was maintained after nerve
injury. Therefore, although adenosine is a potential pain-
relief agent, application of adenosine may not be effective
in postoperative pain compared with that in neuropathic
pain.
OR agonists have been used to treat several types of
neuropathic or postoperative pain. However, several stud-
ies suggest that lOR agonists, like morphine, show
decreased analgesic potency against neuropathic pain [25].
After peripheral nerve injuries, lOR expression signifi-
cantly decreased ipsilateral to nerve injuries in the dorsal
horn [26]. These reports suggest that lOR agonist appli-
cation for treating neuropathic pain after a peripheral injury
is not rational. Relatively large amounts of the agonist may
be required to achieve a large enough analgesic effect,
which may produce considerable side effects such as
constipation or nausea/vomiting. These results suggest that
adenosine may be a reasonable choice for treating neuro-
pathic pain that has not responded well to the opioids.
Clinically, chronic neuropathic pain is one of the most
serious pathological conditions in the field of orthopedic
surgery. As a result of this study, we propose a new possible
therapeutic module for treating neuropathic pain after
peripheral nerve injuries. As most adenosine receptor ago-
nists have a poor blood–brain barrier permeability [27],
intrathecal injection of adenosine A1 receptor agonists, such
as Cl-adenosine or R-PIA using a continuous infusion pump
may effectively inhibit chronic neuropathic pain. Alternative
ideas to increase the adenosine effect are to increase extra-
cellular adenosine concentrations by amplifying production
by Ecto-50-nucleotidase or to inhibit adenosine uptake or
degradation. Propentofylline, an adenosine reuptake inhibi-
tor with a blood–brain barrier permeability, is reported to
inhibit pain behavior after peripheral nerve injury in the rat
[28]. Adenosine reuptake, kinase, and deaminase inhibitors
may provide an avenue for the development of novel thera-
peutic methods against neuropathic pain.
Conclusion
Our study indicates that intrathecally administered adeno-
sine may be an effective pain-relief therapy for neuropathic
pain but is not effective on postoperation pain. We also
found a decrease in adenosine A1 receptors in the spinal
cord dorsal horn of the PI model, which may explain the
variation of adenosine effects among the three pain models.
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